# US 2012/0251609 A1 · Demineralized cancellous bone matrix

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251609 A1
- Document ID: US20120251609A1
- Status: Published application
- Kind: A1
- Application number: 13/074,571
- Filed: 2011-03-29
- Published: 2012-10-04
- Earliest claimed: 2011-03-29
- Inventors: Yen-Chen Huang; Moon Hae Sunwoo; Arthur A. Gertzman
- Web page: https://patentgrep.com/patent/US20120251609A1

## CPC

- A61L 27/3608: {Bone, e.g. demineralised bone matrix [DBM], bone powder}
- A61K 31/728: Hyaluronic acid
- A61K 35/14: Blood; Artificial blood (perfluorocarbons A61K31/02; umbilical cord blood A61K35/51; haemoglobin A61K38/42)
- A61K 35/19: Platelets; Megacaryocytes
- A61K 35/28: Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A61K 35/32: Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- A61K 35/33: Fibroblasts
- A61K 35/36: Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells (islets of Langerhans A61K35/39)
- A61K 38/18: Growth factors; Growth regulators
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61F 2/28: Bones
- A61F 2310/00359: Bone or bony tissue
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A demineralized cancellous bone matrix comprising a cancellous bone matrix that has been demineralized is described herein. The demineralized cancellous bone matrix is rigid and has certain dimensions, including a certain length. Implants comprising at least one demineralized cancellous bone matrix are also described. Also disclosed are methods for treating bone having a void or defect in a patient using at least one demineralized cancellous bone matrix. In addition, methods of making a demineralized cancellous bone matrix are disclosed.

## Claims

### Claim 1

A demineralized cancellous bone matrix comprising a cancellous bone matrix that has been demineralized to contain about 5% to about 20% by weight residual calcium, and wherein the demineralized cancellous bone matrix is rigid and has dimensions, wherein one of the dimensions is a length between about 0.5 mm to about 20 mm.

### Claim 2 (depends on 1)

The demineralized cancellous bone matrix of claim 1, wherein the demineralized cancellous bone matrix has a length between about 2 mm to about 12 mm.

### Claim 3 (depends on 1)

The demineralized cancellous bone matrix of claim 1, wherein the demineralized cancellous bone matrix has a length between about 5 mm to about 10 mm.

### Claim 4 (depends on 1)

The demineralized cancellous bone matrix of claim 1, wherein each of the dimensions of the demineralized cancellous bone matrix is individually between about 0.5 mm to about 20 mm.

### Claim 5 (depends on 1)

The demineralized cancellous bone matrix of claim 1, wherein each of the dimensions of the demineralized cancellous bone matrix is individually between about 2 mm to about 12 mm.

### Claim 6 (depends on 1)

The demineralized cancellous bone matrix of claim 1, wherein each of the dimensions of the demineralized cancellous bone matrix is individually between about 5 mm to about 10 mm.

### Claim 7 (depends on 4)

The demineralized cancellous bone matrix of claim 4, wherein the size of the individual dimensions can vary along the dimensions.

### Claim 8 (depends on 1)

The demineralized cancellous bone matrix of claim 1, wherein the demineralized cancellous bone matrix has a cuboidal shape.

### Claim 9 (depends on 1)

The demineralized cancellous bone matrix of claim 1, wherein at least one surface of the demineralized cancellous bone matrix has an irregular polygonal shape.

### Claim 10 (depends on 1)

The demineralized cancellous bone matrix of claim 1, wherein the cancellous bone matrix has been demineralized to contain about 6% to about 15% by weight residual calcium.

### Claim 11 (depends on 1)

The demineralized cancellous bone matrix of claim 1, wherein the demineralized cancellous bone matrix is formed from human bone.

### Claim 12 (depends on 1)

The demineralized cancellous bone matrix of claim 1, wherein the demineralized cancellous bone matrix is formed from non-human bone.

### Claim 13 (depends on 1)

The demineralized cancellous bone matrix of claim 1, which further comprises at least one additional component.

### Claim 14 (depends on 13)

The demineralized cancellous bone matrix of claim 13, wherein the at least one additional component comprises bone marrow aspirate, blood, platelet rich plasma, platelet rich plasma matrix, stem cells, epithelial cells, fibroblasts, osteoclasts, osteoblasts, chemotactic factors, growth factors, a carrier, cortical bone, or combinations thereof.

### Claim 15 (depends on 14)

The demineralized cancellous bone matrix of claim 14, wherein the carrier comprises saline, phosphate buffered solution, sodium hyaluronate, hyaluronic acid, or combinations thereof.

### Claim 16 (depends on 14)

The demineralized cancellous bone matrix of claim 14, wherein the at least one additional component comprises stem cells comprising mesenchymal stem cells.

### Claim 17 (depends on 1)

The demineralized cancellous bone matrix of claim 1, wherein the demineralized cancellous bone matrix includes less than or equal to about 10% by weight of cortical bone.

### Claim 18 (depends on 1)

The demineralized cancellous bone matrix of claim 1, wherein the demineralized cancellous bone matrix includes less than or equal to about 5% by weight of growth factors, or less than or equal to about 5% by weight of connective tissue.

### Claim 19

An implant comprising at least one demineralized cancellous bone matrix, wherein the at least one demineralized cancellous bone matrix comprises a cancellous bone matrix that has been demineralized to contain about 5% to about 20% by weight residual calcium, and wherein the at least one demineralized cancellous bone matrix is rigid and has dimensions, wherein one of the dimensions is a length between about 0.5 mm to about 20 mM.

### Claim 20 (depends on 19)

The implant of claim 19, wherein the at least one demineralized cancellous bone matrix has a length between about 2 mm to about 12 mm.

### Claim 21 (depends on 19)

The implant of claim 19, wherein the at least one demineralized cancellous bone matrix has a length between about 5 mm to about 10 mm.

### Claim 22 (depends on 19)

The implant of claim 19, wherein each of the dimensions of the demineralized cancellous bone matrix is individually between about 0.5 mm to about 20 mm.

### Claim 23 (depends on 19)

The implant of claim 19, wherein each of the dimensions of the demineralized cancellous bone matrix is individually between about 2 mm to about 12 mm.

### Claim 24 (depends on 19)

The implant of claim 19, wherein each of the dimensions of the demineralized cancellous bone matrix is individually between about 5 mm to about 10 mm.

### Claim 25 (depends on 22)

The implant of claim 22, wherein the size of the individual dimensions can vary along the dimensions.

### Claim 26 (depends on 19)

The implant of claim 19, wherein the at least one demineralized cancellous bone matrix has a cuboidal shape.

### Claim 27 (depends on 19)

The implant of claim 19, wherein at least one surface of the at least one demineralized cancellous bone matrix has an irregular polygonal shape.

### Claim 28 (depends on 19)

The implant of claim 19, wherein the cancellous bone matrix has been demineralized to contain about 6% to about 15% by weight residual calcium.

### Claim 29 (depends on 19)

The implant of claim 19, wherein the at least one demineralized cancellous bone matrix is formed from human bone.

### Claim 30 (depends on 19)

The implant of claim 19, wherein the at least one demineralized cancellous bone matrix is formed from non-human bone.

### Claim 31 (depends on 19)

The implant of claim 19, which further comprises at least one additional component.

### Claim 32 (depends on 31)

The implant of claim 31, wherein the at least one additional component comprises bone marrow aspirate, blood, platelet rich plasma, platelet rich plasma matrix, stem cells, epithelial cells, fibroblasts, osteoclasts, osteoblasts, chemotactic factors, growth factors, a carrier, cortical bone, or combinations thereof.

### Claim 33 (depends on 32)

The implant of claim 32, wherein the carrier comprises saline, phosphate buffered solution, sodium hyaluronate, hyaluronic acid, or combinations thereof.

### Claim 34 (depends on 32)

The implant of claim 32, wherein the at least one additional component comprises stem cells comprising mesenchymal stem cells.

### Claim 35 (depends on 19)

The implant of claim 19, wherein the at least one demineralized cancellous bone matrix includes less than or equal to about 10% by weight of cortical bone.

### Claim 36 (depends on 19)

The implant of claim 19, wherein the at least one demineralized cancellous bone matrix includes less than or equal to about 5% by weight of growth factors, or less than or equal to about 5% by weight of connective tissue.

### Claim 37

A method of treating bone having a void or defect in a patient in need thereof, the method comprising inserting into the void or defect at least one demineralized cancellous bone matrix, wherein the at least one demineralized cancellous bone matrix comprises a cancellous bone matrix that has been demineralized to contain about 5% to about 20% by weight residual calcium, and wherein the at least one demineralized cancellous bone matrix is rigid and has dimensions, wherein one of the dimensions is a length between about 0.5 mm to about 20 mm.

### Claim 38 (depends on 37)

The method of claim 37, wherein the at least one demineralized cancellous bone matrix promotes bone growth in the void or defect.

### Claim 39 (depends on 37)

The method of claim 37, wherein the void or defect is related to a trauma or a cancer.

### Claim 40 (depends on 37)

The method of claim 37 wherein the at least one demineralized cancellous bone matrix has a length between about 2 mm to about 12 mm.

### Claim 41 (depends on 37)

The method of claim 37 wherein the at least one demineralized cancellous bone matrix has a length between about 5 mm to about 10 mm.

### Claim 42 (depends on 37)

The method of claim 37, wherein each of the dimensions of the demineralized cancellous bone matrix is individually between about 0.5 mm to about 20 mm.

### Claim 43 (depends on 37)

The method of claim 37, wherein each of the dimensions of the demineralized cancellous bone matrix is individually between about 2 mm to about 12 mm.

### Claim 44 (depends on 37)

The method of claim 37, wherein each of the dimensions of the demineralized cancellous bone matrix is individually between about 5 mm to about 10 mm.

### Claim 45 (depends on 42)

The method of claim 42, wherein the size of the individual dimensions can vary along the dimensions.

### Claim 46 (depends on 37)

The method of claim 37 wherein the at least one demineralized cancellous bone matrix has a cuboidal shape.

### Claim 47 (depends on 37)

The method of claim 37 wherein at least one surface of the at least one demineralized cancellous bone matrix has an irregular polygonal shape.

### Claim 48 (depends on 37)

The method of claim 37 wherein the cancellous bone matrix has been demineralized to contain about 6% to about 15% by weight residual calcium.

### Claim 49 (depends on 37)

The method of claim 37 wherein the at least one demineralized cancellous bone matrix is formed from human bone.

### Claim 50 (depends on 37)

The method of claim 37 wherein the at least one demineralized cancellous bone matrix is formed from non-human bone.

### Claim 51 (depends on 37)

The method of claim 37, wherein the at least one demineralized cancellous bone matrix further comprises at least one additional component.

### Claim 52 (depends on 51)

The method of claim 51 wherein the at least one additional component comprises bone marrow aspirate, blood, platelet rich plasma, platelet rich plasma matrix, stem cells, epithelial cells, fibroblasts, osteoclasts, osteoblasts, chemotactic factors, growth factors, a carrier, cortical bone, or combinations thereof.

### Claim 53 (depends on 52)

The method of claim 52, wherein the carrier comprises saline, phosphate buffered solution, sodium hyaluronate, hyaluronic acid, or combinations thereof.

### Claim 54 (depends on 52)

The method of claim 52 wherein the at least one additional component comprises stem cells comprising mesenchymal stem cells.

### Claim 55 (depends on 37)

The method of claim 37 wherein the at least one demineralized cancellous bone matrix includes less than or equal to about 10% by weight of cortical bone.

### Claim 56 (depends on 37)

The method of claim 37 wherein the at least one demineralized cancellous bone matrix includes less than or equal to about 5% by weight of growth factors, or less than or equal to about 5% by weight of connective tissue.

### Claim 57

A method of treating a spinal disc in a patient in need thereof, the method comprising:
forming at least one cavity located between two adjacent vertebral bodies; and
inserting into the cavity at least one demineralized cancellous bone matrix, wherein the at least one demineralized cancellous bone matrix comprises a cancellous bone matrix that has been demineralized to contain about 5% to about 20% by weight residual calcium, and wherein the at least one demineralized cancellous bone matrix is rigid and has dimensions, wherein one of the dimensions is a length between about 0.5 mm to about 20 mM.

### Claim 58 (depends on 57)

The method of claim 57, wherein the cavity is located within the spinal disc.

### Claim 59 (depends on 57)

The method of claim 57, wherein the at least one demineralized cancellous bone matrix promotes bone growth in the cavity.

### Claim 60 (depends on 57)

The method of claim 57, wherein the at least one demineralized cancellous bone matrix is used to create a fusion between the two adjacent vertebral bodies.

### Claim 61 (depends on 57)

The method of claim 57, wherein the spinal disc is degenerated and the method is for treating the degenerated spinal disc.

### Claim 62 (depends on 57)

The method of claim 57 wherein the at least one demineralized cancellous bone matrix has a length between about 2 mm to about 12 mm.

### Claim 63 (depends on 57)

The method of claim 57 wherein the at least one demineralized cancellous bone matrix has a length between about 5 mm to about 10 mm.

### Claim 64 (depends on 57)

The method of claim 57, wherein each of the dimensions of the demineralized cancellous bone matrix is individually between about 0.5 mm to about 20 mm.

### Claim 65 (depends on 57)

The method of claim 57, wherein each of the dimensions of the demineralized cancellous bone matrix is individually between about 2 mm to about 12 mm.

### Claim 66 (depends on 57)

The method of claim 57, wherein each of the dimensions of the demineralized cancellous bone matrix is individually between about 5 mm to about 10 mm.

### Claim 67 (depends on 64)

The method of claim 64, wherein the size of the individual dimensions can vary along the dimensions.

### Claim 68 (depends on 57)

The method of claim 57 wherein the at least one demineralized cancellous bone matrix has a cuboidal shape.

### Claim 69 (depends on 57)

The method of claim 57 wherein at least one surface of the at least one demineralized cancellous bone matrix has an irregular polygonal shape.

### Claim 70 (depends on 57)

The method of claim 57 wherein the cancellous bone matrix has been demineralized to contain about 6% to about 15% by weight residual calcium.

### Claim 71 (depends on 57)

The method of claim 57 wherein the at least one demineralized cancellous bone matrix is formed from human bone.

### Claim 72 (depends on 57)

The method of claim 57 wherein the at least one demineralized cancellous bone matrix is formed from non-human bone.

### Claim 73 (depends on 57)

The method of claim 57, wherein the at least one demineralized cancellous bone matrix further comprises at least one additional component.

### Claim 74 (depends on 73)

The method of claim 73, wherein the at least one additional component comprises bone marrow aspirate, blood, platelet rich plasma, platelet rich plasma matrix, stem cells, epithelial cells, fibroblasts, osteoclasts, osteoblasts, chemotactic factors, growth factors, a carrier, cortical bone, or combinations thereof.

### Claim 75 (depends on 74)

The method of claim 74, wherein the carrier comprises saline, phosphate buffered solution, sodium hyaluronate, hyaluronic acid, or combinations thereof.

### Claim 76 (depends on 74)

The method of claim 74 wherein the at least one additional component comprises stem cells comprising mesenchymal stem cells.

### Claim 77 (depends on 57)

The method of claim 57 wherein the at least one demineralized cancellous bone matrix includes less than or equal to about 10% by weight of cortical bone.

### Claim 78 (depends on 57)

The method of claim 57 wherein the at least one demineralized cancellous bone matrix includes less than or equal to about 5% by weight of growth factors, or less than or equal to about 5% by weight of connective tissue.

### Claim 79

A method of making a demineralized cancellous bone matrix comprising demineralizing a cancellous bone matrix to contain about 5% to about 20% by weight residual calcium, wherein the demineralized cancellous bone matrix is rigid and has dimensions, wherein one of the dimensions is a length between about 0.5 mm to about 20 mm, and wherein the demineralized cancellous bone matrix is made by a process comprising:
a. cutting bone to obtain the cancellous bone matrix, wherein the cancellous bone matrix has a length between about 0.5 mm to about 20 mm; and
b. demineralizing the cancellous bone matrix so that the residual calcium in the cancellous bone matrix is about 5% to about 20% by weight.

### Claim 80 (depends on 79)

The method of claim 79, wherein the cancellous bone matrix has a length between about 2 mm to about 12 mm.

### Claim 81 (depends on 79)

The method of claim 79, wherein the cancellous bone matrix has a length between about 5 mm to about 10 mm.

### Claim 82 (depends on 79)

The method claim 79, wherein each of the dimensions of the demineralized cancellous bone matrix is individually between about 0.5 mm to about 20 mm.

### Claim 83 (depends on 79)

The method of claim 79, wherein each of the dimensions of the demineralized cancellous bone matrix is individually between about 2 mm to about 12 mm.

### Claim 84 (depends on 79)

The method of claim 79, wherein each of the dimensions of the demineralized cancellous bone matrix is individually between about 5 mm to about 10 mm.

### Claim 85 (depends on 82)

The method of claim 82, wherein the size of the individual dimensions can vary along the dimensions.

### Claim 86 (depends on 79)

The method of claim 79, wherein the demineralized cancellous bone matrix has a cuboidal shape.

### Claim 87 (depends on 79)

The method of claim 79, wherein the demineralized cancellous bone matrix has an irregular polygonal shape.

### Claim 88 (depends on 79)

The method of claim 79, wherein the cancellous bone matrix is demineralized in hydrochloric acid.

### Claim 89 (depends on 88)

The method of claim 88, wherein the hydrochloric acid is about 0.2N to about 1.0N.

### Claim 90 (depends on 88)

The method of claim 88, wherein the hydrochloric acid is about 0.3N to about 0.6N.

### Claim 91 (depends on 79)

The method of claim 79, wherein the cancellous bone matrix is demineralized for about 2 minutes to about 15 minutes.

### Claim 92 (depends on 79)

The method of claim 79, wherein the cancellous bone matrix is demineralized for about 5 minutes to about 10 minutes.

### Claim 93 (depends on 88)

The method of claim 88, wherein the hydrochloric acid is about 0.2N to about 0.5N and wherein the cancellous bone matrix is demineralized for about 5 minutes to about 10 minutes.

### Claim 94 (depends on 79)

The method of claim 79, wherein the cancellous bone matrix is demineralized to contain about 6% to about 15% by weight residual calcium.

### Claim 95 (depends on 79)

The method of claim 79, wherein the demineralized cancellous bone matrix is formed from human bone.

### Claim 96 (depends on 79)

The method of claim 79, wherein the demineralized cancellous bone matrix is formed from non-human bone.

### Claim 97 (depends on 79)

The method of claim 79, wherein the process further comprises exposing the demineralized cancellous bone matrix to one or more bone cleaning agents.

### Claim 98 (depends on 97)

The method of claim 97, wherein the demineralized cancellous bone matrix is exposed to the one or more bone cleaning agents before demineralizing the cancellous bone matrix.

### Claim 99 (depends on 97)

The method of claim 97, wherein the demineralized cancellous bone matrix is exposed to the one or more bone cleaning agents after demineralizing the cancellous bone matrix.

### Claim 100 (depends on 97)

The method of claim 97, wherein the demineralized cancellous bone matrix is exposed to the one or more bone cleaning agents before and after demineralizing the cancellous bone matrix.

### Claim 101 (depends on 97)

The method of claim 97, wherein the one or more bone cleaning agent comprises hydrogen peroxide, a detergent, an antibiotic, an alcohol, or combinations thereof.

### Claim 102 (depends on 97)

The method of claim 97, wherein the demineralized cancellous bone matrix is sonicated in the one or more bone cleaning agent.

### Claim 103 (depends on 97)

The method of claim 97, wherein the demineralized cancellous bone matrix is agitated in the one or more bone cleaning agent.

### Claim 104 (depends on 103)

The method of claim 103, wherein the demineralized cancellous bone matrix is agitated by mechanical stirring.

### Claim 105 (depends on 97)

The method of claim 97 wherein the demineralized cancellous bone matrix is soaked in the one or more bone cleaning agent.

### Claim 106 (depends on 79)

The method of claim 79, wherein the process further comprises combining the demineralized cancellous bone matrix with at least one additional component.

### Claim 107 (depends on 106)

The method of claim 106, wherein the at least one additional component comprises bone marrow aspirate, blood, platelet rich plasma, platelet rich plasma matrix, stem cells, epithelial cells, fibroblasts, osteoclasts, osteoblasts, chemotactic factors, growth factors, a carrier, cortical bone, or combinations thereof.

### Claim 108 (depends on 107)

The method of claim 107, wherein the carrier comprises saline, phosphate buffered solution, sodium hyaluronate, hyaluronic acid, or combinations thereof.

### Claim 109 (depends on 107)

The method of claim 107, wherein the at least one additional component comprises stem cells comprising mesenchymal stem cells.

### Claim 110 (depends on 79)

The method of claim 79, wherein the demineralized cancellous bone matrix includes less than or equal to about 10% by weight of cortical bone.

### Claim 111 (depends on 79)

The method of claim 79, wherein the demineralized cancellous bone matrix includes less than or equal to about 5% by weight of growth factors, or less than or equal to about 5% by weight of connective tissue.
